Regulatory Considerations for Approval of Chimeric Antigen Receptor T Cell Therapies for Treatment of Hematological MalignanciesMona Elmacken, Lola A. Fashoyin‐Aje, Upendra Mahat et al.|Blood|2024Cited by 2